Moheb Afzali , Fereshteh, et al. “BCc1, a Chelation-Based Nanomedicine, Modulates Splenic Cytokine Networks Toward a Profile Associated With Antitumor Immunity in 4T1 Breast tumor–bearing Mice”. Archives of Advances in Biosciences, vol. 17, no. 1, May 2026, pp. 1-13, doi:10.22037/aab.v16i1.52004.